Enzymatic synthesis of random sequences of RNA and RNA analogues by DNA polymerase theta mutants for the generation of aptamer libraries

Abstract Nucleic acid aptamers, especially RNA, exhibit valuable advantages compared to protein therapeutics in terms of size, affinity and specificity. However, the synthesis of libraries of large random RNAs is still difficult and expensive. The engineering of polymerases able to directly generate these libraries has the potential to replace the chemical synthesis approach. Here, we start with a DNA polymerase that already displays a significant template-free nucleotidyltransferase activity, human DNA polymerase theta, and we mutate it based on the knowledge of its three-dimensional structure as well as previous mutational studies on members of the same polA family. One mutant exhibited a high tolerance towards ribonucleotides (NTPs) and displayed an efficient ribonucleotidyltransferase activity that resulted in the assembly of long RNA polymers. HPLC analysis and RNA sequencing of the products were used to quantify the incorporation of the four NTPs as a function of initial NTP concentrations and established the randomness of each generated nucleic acid sequence. The same mutant revealed a propensity to accept other modified nucleotides and to extend them in long fragments. Hence, this mutant can deliver random natural and modified RNA polymers libraries ready to use for SELEX, with custom lengths and balanced or unbalanced ratios.

[1]  Lloyd M. Smith,et al.  2'-Fluoro modified nucleic acids: polymerase-directed synthesis, properties and stability to analysis by matrix-assisted laser desorption/ionization mass spectrometry. , 1997, Nucleic acids research.

[2]  R. Pomerantz,et al.  Polymerase θ is a robust terminal transferase that oscillates between three different mechanisms during end-joining , 2016, eLife.

[3]  H. Tilly,et al.  Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Samuel H. Wilson,et al.  Identification of 5'-deoxyribose phosphate lyase activity in human DNA polymerase gamma and its role in mitochondrial base excision repair in vitro. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Frédéric Poitevin,et al.  Structural basis for a novel mechanism of DNA bridging and alignment in eukaryotic DSB DNA repair , 2015, The EMBO journal.

[6]  R. Wood,et al.  Human DNA polymerase θ grasps the primer terminus to mediate DNA repair , 2015, Nature Structural &Molecular Biology.

[7]  R. Schooley,et al.  Vidarabine versus acyclovir therapy in herpes simplex encephalitis. , 1986, The New England journal of medicine.

[8]  Z. Suo,et al.  Unlocking the sugar "steric gate" of DNA polymerases. , 2011, Biochemistry.

[9]  D. Engelke,et al.  Ribozymes: catalytic RNAs that cut things, make things, and do odd and useful jobs. , 2002, Biologist.

[10]  J. Hope,et al.  Characterization of 2′-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion* , 2003, Journal of Biological Chemistry.

[11]  F. Eckstein,et al.  Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. , 1991, Science.

[12]  C. M. Joyce,et al.  A single side chain prevents Escherichia coli DNA polymerase I (Klenow fragment) from incorporating ribonucleotides. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Breaker Riboswitches and the RNA world. , 2012, Cold Spring Harbor perspectives in biology.

[14]  L. Loeb,et al.  Getting a grip on how DNA polymerases function , 2001, Nature Structural Biology.

[15]  Gabriel Waksman,et al.  Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase I: structural basis for nucleotide incorporation , 1998, The EMBO journal.

[16]  Jiehua Zhou,et al.  Aptamers as targeted therapeutics: current potential and challenges , 2017, Nature Reviews Drug Discovery.

[17]  J. Rothnagel,et al.  Enzymatic Recognition of 2′‐Modified Ribonucleoside 5′‐Triphosphates: Towards the Evolution of Versatile Aptamers , 2012, Chembiochem : a European journal of chemical biology.

[18]  F. Romesberg,et al.  Polymerase Chain Transcription: Exponential Synthesis of RNA and Modified RNA. , 2017, Journal of the American Chemical Society.

[19]  B. Shen,et al.  RNA aptamers specific for bovine thrombin , 2003, Journal of molecular recognition : JMR.

[20]  P. Holliger,et al.  Directed evolution of DNA polymerase, RNA polymerase and reverse transcriptase activity in a single polypeptide. , 2006, Journal of molecular biology.

[21]  Clement T Y Chan,et al.  Quantitative analysis of ribonucleoside modifications in tRNA by HPLC-coupled mass spectrometry , 2014, Nature Protocols.

[22]  M. Hollenstein,et al.  Generation of Aptamers with an Expanded Chemical Repertoire , 2015, Molecules.

[23]  P H Patel,et al.  DNA polymerase active site is highly mutable: evolutionary consequences. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Kevin M. Bradley,et al.  Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory Evolution. , 2016, Angewandte Chemie.

[25]  J. Ito,et al.  Compilation, alignment, and phylogenetic relationships of DNA polymerases. , 1993, Nucleic acids research.

[26]  E. Kool,et al.  DNA polymerase θ specializes in incorporating synthetic expanded-size (xDNA) nucleotides , 2016, Nucleic acids research.

[27]  T. Steitz DNA Polymerases: Structural Diversity and Common Mechanisms* , 1999, The Journal of Biological Chemistry.

[28]  R. Wood,et al.  Lesion bypass activity of DNA polymerase θ (POLQ) is an intrinsic property of the pol domain and depends on unique sequence inserts. , 2011, Journal of molecular biology.

[29]  L. Blanco,et al.  Limited terminal transferase in human DNA polymerase μ defines the required balance between accuracy and efficiency in NHEJ , 2009, Proceedings of the National Academy of Sciences.

[30]  Sarah L. DeVos,et al.  Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNA , 2013, Neurotherapeutics.

[31]  G. Maga,et al.  Human DNA polymerase lambda possesses terminal deoxyribonucleotidyl transferase activity and can elongate RNA primers: implications for novel functions. , 2003, Journal of molecular biology.

[32]  J. DeStefano,et al.  Selection of 2′-deoxy-2′-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinity , 2015, Nucleic acids research.

[33]  S. Crooke Antisense Drug Technology , 2001 .

[34]  Jason D. Fowler,et al.  Biochemical, structural, and physiological characterization of terminal deoxynucleotidyl transferase. , 2006, Chemical reviews.

[35]  R. Pomerantz,et al.  DNA Polymerase θ: A Unique Multifunctional End-Joining Machine , 2016, Genes.

[36]  Wei Yang,et al.  How a homolog of high-fidelity replicases conducts mutagenic DNA synthesis , 2015, Nature Structural &Molecular Biology.

[37]  X. Le,et al.  Aptamer binding assays for proteins: the thrombin example--a review. , 2014, Analytica chimica acta.

[38]  D. Bunka,et al.  Development of aptamer therapeutics. , 2010, Current opinion in pharmacology.

[39]  P Argos,et al.  An attempt to unify the structure of polymerases. , 1990, Protein engineering.

[40]  R. Stoltenburg,et al.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. , 2007, Biomolecular engineering.

[41]  R. Wood,et al.  DNA polymerase θ (POLQ), double-strand break repair, and cancer. , 2016, DNA repair.

[42]  Aaron M. Leconte,et al.  Taq DNA Polymerase Mutants and 2'-Modified Sugar Recognition. , 2015, Biochemistry.

[43]  Thomas A. Steitz,et al.  Structure of Taq polymerase with DNA at the polymerase active site , 1996, Nature.

[44]  C. Papanicolaou,et al.  Crystal structures of a template‐independent DNA polymerase: murine terminal deoxynucleotidyltransferase , 2002, The EMBO journal.

[45]  P. Borer,et al.  Revised UV extinction coefficients for nucleoside-5'-monophosphates and unpaired DNA and RNA. , 2004, Nucleic acids research.

[46]  T. Lavergne,et al.  Efficient and sequence-independent replication of DNA containing a third base pair establishes a functional six-letter genetic alphabet , 2012, Proceedings of the National Academy of Sciences.

[47]  G. Mayer The chemical biology of aptamers. , 2009, Angewandte Chemie.

[48]  R. Veedu,et al.  In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies , 2016, RNA biology.

[49]  J. Montserrat,et al.  Modified Nucleoside Triphosphates for In-vitro Selection Techniques , 2016, Front. Chem..

[50]  S. Doublié,et al.  Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 Å resolution , 1998, Nature.

[51]  Robert W. Taylor,et al.  Nucleotide pools dictate the identity and frequency of ribonucleotide incorporation in mitochondrial DNA , 2017, PLoS genetics.

[52]  N. Grishin,et al.  PROMALS3D: a tool for multiple protein sequence and structure alignments , 2008, Nucleic acids research.

[53]  M. Delarue,et al.  Structural Basis for a New Templated Activity by Terminal Deoxynucleotidyl Transferase: Implications for V(D)J Recombination. , 2016, Structure.

[54]  C. Papanicolaou,et al.  Terminal Deoxynucleotidyl Transferase Indiscriminately Incorporates Ribonucleotides and Deoxyribonucleotides* , 2001, The Journal of Biological Chemistry.